Body weight Dose-dependent reductions in body weight were evident vs placebo with tirzepatide 5 mg (6.31 kg [95% CI 4.38, 8.25], I 2 70%), 10 mg (8.43 kg [95% CI 6.77, 10.09], I 2 68%) and 15 mg (9.36 kg [95% CI 6.20, 12.53], I 2 91%) (Fig
Role of gastrointestinal hormones in postprandial reduction of bone resorption
However, whether the human body can also benefit from the approach remains to be seen
In fact, subcutaneous administration is the most common means of administering the vast majority of peptides
The downside of light therapy is that it can cause premature aging of the skin and increases the risk of skin cancer, which is why it is not often used on young children